Tenderwize
Back to tender search

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Techniker Krankenkasse·Hamburg, Germany·Deadline Feb 27, 2027 · 193 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-06 - Dolutegravir

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Feb 2027
  • Supply of pharmaceutical products for the active substance Dolutegravir.
  • Open House contract for rebate agreements under Section 130c(1) SGB V.
Show full summary

This is a German Open House pharmaceutical supply arrangement for Dolutegravir (CPV 33600000) led by Techniker Krankenkasse, with HEK and hkk listed as participating buyers. It is not a classic competitive award procedure: TK states that all suitable pharmaceutical companies meeting the stated conditions may join, with no exclusivity and no individual negotiations. The contract term runs up to 24 months from 2025-03-01 and ends no later than 2027-02-28, with possible earlier automatic end on patent/market exclusivity expiry. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the TED XML notice.

Risks

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical company within the meaning of Section 4(18) AMG for the relevant medicinal products.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Open House supply arrangement for Dolutegravir. The lot covers nationwide performance in Germany and is intended for pharmaceutical companies that can supply/market the relevant medicinal product and meet the stated Open House eligibility conditions. The notice says participation is possible throughout the contract period, subject to the stated conditions. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Feb 2025 - Feb 2027

Category

Pharmaceutical products

Deadline

Deadline Feb 27, 2027

Procurement Details

Publication date
20 Jan 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
42663-2025

Documents (1)

Similar tenders